Aigen Investment Management’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,287
Closed -$245K 1021
2023
Q3
$245K Buy
+9,287
New +$280K 0.05% 595
2022
Q2
Sell
-6,726
Closed -$356K 688
2022
Q1
$356K Buy
+6,726
New +$354K 0.06% 336
2021
Q4
Sell
-13,704
Closed -$913K 1154
2021
Q3
$913K Buy
13,704
+5,762
+73% +$450K 0.18% 155
2021
Q2
$729K Buy
+7,942
New +$782K 0.13% 175
2021
Q1
Sell
-6,383
Closed -$979K 831
2020
Q4
$979K Buy
6,383
+1,374
+27% +$194K 0.13% 209
2020
Q3
$649K Sell
5,009
-6,035
-55% -$793K 0.08% 356
2020
Q2
$1.24M Buy
11,044
+10,876
+6,474% +$1.12M 0.16% 195
2020
Q1
$13K Sell
168
-2,649
-94% -$245K ﹤0.01% 1134
2019
Q4
$286K Buy
+2,817
New +$279K 0.05% 452

Other funds holding PRLB

Aigen Investment Management's PRLB Position: Q4 2023 in Review

Aigen Investment Management sold out of Protolabs (PRLB) in Q4 2023, closing a stake of 9,287 shares — an estimated $245K sold.

Aigen Investment Management first reported a position in PRLB in Q4 2019 and held it in 9 quarters. The position peaked at $1.24M in Q2 2020. 219 funds tracked by Wall St. Rank hold PRLB as of Q4 2023.

  • Aigen Investment Management reported no remaining Protolabs position as of Q4 2023 after selling out during the quarter.
  • Aigen Investment Management sold 9,287 Protolabs shares in Q4 2023, an estimated $245K.
  • Aigen Investment Management first reported a position in Protolabs in Q4 2019 and held it in 9 quarters.
  • Aigen Investment Management's Protolabs position peaked at $1.24M in Q2 2020.
  • 219 funds tracked by Wall St. Rank held Protolabs as of Q4 2023.

Based on Aigen Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.